Formulation and Evaluation of Norfloxacin Ocular In-situ Gel
Abstract
The study aims to prepare and evaluate the in situ Norfloxacin gel for the treatment of Conjunctivitis. The pronounced fluctuations and repeated administration of conventional eye drops are the main disadvantages of ophthalmic drug delivery. The ocular in situ gelling system is designed to achieve a prolonged therapeutic effect by improving residence time at the application site. Infrared spectroscopy studies of Norfloxacin, Sodium alginate, Gellan gum, and HPMC K4M alone and their physical mixture revealed that Norfloxacin is compatible with all the polymers used. The Ophthalmic in situ gelling system of Norfloxacin was successfully formulated using different gelling agents viz. Sodium alginate, Gellan gum, and HPMC K4M are viscosity-enhancing agents. Prepared in situ gels were subjected to evaluation such as visual appearance, pH, and drug content. All formulations were found transparent and clear, the pH of the formulations was between 7.1 to 7.4, and drug content was found within 95-98% in all in situ gelling systems. All the formulations showed instantaneous gelation when contacted with simulated tear fluid. The viscosity of all formulations decreased as the shear rate increased, indicating the pseudoplastic fluid's character. In vitro release of Norfloxacin from the prepared formulations was studied for 6 hours. Results reveal that all formulations exhibited sustained release of the drug from the gelrite polymeric network over 6 hrs. The stability studies confirmed that in situ gelling formulations of Norfloxacin remained more stable at ambient temperature and humidity. The present work was a satisfactory preliminary study in developing in situ gelling systems of Norfloxacin.
Keywords: Conjunctivitis, Norfloxacin, in situ gel, Sodium alginate, sustained release.
Keywords:
Conjunctivitis, Norfloxacin, in situ gel, Sodium alginate, sustained releaseDOI
https://doi.org/10.22270/jddt.v12i5-S.5644References
El-Emam GA, Girgis GNS, El-Sokkary MMA, El-Azeem Soliman OA, Abd El Gawad AEGH, Ocular Inserts of Voriconazole-Loaded Proniosomal Gels: Formulation, Evaluation and Microbiological Studies, Int J Nanomedicine, 2020; 15:7825-7840. https://doi.org/10.2147/IJN.S268208
Sandeep DS, Charyulu RN and Dubey A, Sustained release ophthalmic in-situ gels of dorzolamide HCl for glaucoma-an approach to formulation and in-vitro evaluation, Int J Pharm Sci & Res, 2020; 11(12):6425-33.
Guven UM, Berkman MS, Senel B, Yazan Y, Development and in vitro/in vivo evaluation of thermo-sensitive in situ gelling systems for ocular allergy, Braz J Pharm Sci, 2019; 55:e17511. https://doi.org/10.1590/s2175-97902019000117511
Kurniawansyah I, Rusdiana T, Wahab H, Subarnas A, In Situ Opthalmic Gel With Ion Activated System, International Journal of Applied Pharmaceutics, 2019; 15-18. https://doi.org/10.22159/ijap.2019v11i4.33072
Irimia T, Dinu-Pîrvu CE, Ghica MV, Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review, Mar Drugs, 2018; 16(10):373. https://doi.org/10.3390/md16100373
Kataria P, Katara R, Sahoo PK, Sachdeva S, Dorzolamide in situ Gel Forming System: Characterization and Evaluation for Glaucoma Treatment, Madridge J Pharm Res, 2017; 1(1):13-21. https://doi.org/10.18689/mjpr-1000103
Wu Y, Liu Y, Li X, Kebebe D, Zhang B, Ren J, Research progress of in-situ gelling ophthalmic drug delivery system, Asian Journal of Pharmaceutical Sciences, 2019; 14(1):1-15. https://doi.org/10.1016/j.ajps.2018.04.008
Khurana LK, Singh R, Singh H, Sharma M, Systematic Development and Optimization of an insitu Gelling System for Moxifloxacin Ocular Nanosuspension using High-pressure Homogenization with an Improved Encapsulation Efficiency, Curr Pharm Des, 2018; 24(13): 1434-45. https://doi.org/10.2174/1381612824666180403115106
Ranch KM, Maulvi FA, Naik MJ, Koli AR, Parikh RK, Shah DO, Optimization of a novel in situ gel for sustained ocular drug delivery using Box-Behnken design: In vitro, ex vivo, in vivo and human studies, Int J Pharm, 2019; 554:264-75. https://doi.org/10.1016/j.ijpharm.2018.11.016
Nigussie Y, Melaku A, Tadese M, Belete B, Kebede E, Quality of injectable oxytetracycline circulating in legal markets of Addis Ababa, Ethiopia using physiochemical and sterility analysis. Ethiopian Veterinary Journal, 2021; 25(2):14-26. https://doi.org/10.4314/evj.v25i2.2
Sun SB, Liu P, Shao F-M, Miao QL, Formulation and evaluation of PLGA nanoparticles loaded capecitabine for prostate cancer, Int J Clin Exp Med, 2015; 8(10):19670-81.
Nair AB, Shah J, Jacob S, Al-Dhubiab BE, Sreeharsha N, Morsy MA, Experimental design, formulation and in vivo evaluation of a novel topical in situ gel system to treat ocular infections, PLoS ONE, 2021; 16(3):e0248857. https://doi.org/10.1371/journal.pone.0248857
Xu Y, Zhu Y, Complete replacement of nitrite with a Lactobacillus fermentum on the quality and safety of Chinese fermented sausages, Front Microbiol, 2021; 12:704302. https://doi.org/10.3389/fmicb.2021.704302
Kotzev DL, Heat sterilization of cyanoacrylate, US Patent, 6136326, 2000.
Dieci M, Llibre-Rodriguez JJ, Acosta D, Dow WH, Cuba's cardiovascular risk factors: International comparison of levels and education gradients, PLoS One, 2021; 16(3):e0247831. https://doi.org/10.1371/journal.pone.0247831
Suchita G, Ion - Activated In Situ Gelling System of Levofloxacin for Sustained Ophthalmic Delivery, American Journal of PharmTech Research, 2020; 10(6):33-41. https://doi.org/10.46624/ajptr.2020.v10.i6.003
Sanaboina J, Maheswari KM, Sunkara S, Deekonda S, Nalluri BN. Preparation and evaluation of valsartan liquid filling formulations for soft gels, J Pharm (Cairo), 2013; 418346. https://doi.org/10.1155/2013/418346
Published
Abstract Display: 989 
PDF Downloads: 766 PDF Downloads: 189 How to Cite
Issue
Section
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
How to Cite
.